Skip to main content
. 2016 Nov 23;7(52):87180–87193. doi: 10.18632/oncotarget.13517

Table 4. The associations between rs3754093 and clinical characteristics of hepatocellular carcinoma patients.

Variables AA AG/GG OR(95%CI)a OR(95%CI)b
tumor size
 ≥5cm 85(34.56) 161(63.44) 1.000 1.000
 <5cm 217(29.17) 527(70.83) 1.282(0.944∼1.742) 1.165 (0.876∼1.963)
tumor number
 solitary 267(30.58) 606(69.42) 1.000 1.000
 multiple 35(29.91) 82(70.09) 1.032(0.677∼1.573) 0.972 (0.596∼2.248)
TNM staging
 T1+T2 262(31.30) 575(68.70) 1.000 1.000
 T3+T4 40(26.14) 113(74.86) 1.287(0.872∼1.899) 1.196 (0.756∼1.972)
Combined with liver cirrhosis
 Yes 100(23.98) 317(76.02) 1.000 1.000
 No 202(35.25) 371(64.75) 0.579(0.437∼0.769) 0.585 (0.446∼0.756)
AFP level (ng/ml)
 ≥400 205 (29.45) 491(70.55) 1.000 1.000
 <400 97 (37.16) 164(62.84) 0.706 (0.523∼0.952) 0.681 (0.434∼1.051)
tumor metastasis
 Yes 53(40.15) 79(59.85) 1.000 1.000
 No 249(29.02) 609(70.98) 1.641(1.124∼2.394) 1.535 (1.023∼2.538)

a: OR (95% CI) not adjusted; b: OR (95% CI) adjusted for age, gender, nations, smoking, alcohol consumption, HBV infection, and HCC family history.